Differences in the curing of [PSI+] prion by various methods of Hsp104 inactivation

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Park, Yang Nim ^a   Morales, David ^a   Rubinson, Emily H ^a   Masison, Daniel ^b   Eisenberg, Evan ^a   Greene, Lois E ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; GUANIDINE; HEAT SHOCK PROTEIN 104; MUTANT PROTEIN;

ARTICLE; CELL COUNT; CELL GROWTH; CONTROLLED STUDY; CURING; DISEASE COURSE; DISEASE SEVERITY; FLUORESCENCE ANALYSIS; NONHUMAN; PRION; PROCEDURES CONCERNING CELLS; PROTEIN CONFORMATION; PROTEIN DEFECT; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN UNFOLDING; YEAST;

BLOTTING, WESTERN; HEAT-SHOCK PROTEINS; MICROSCOPY, CONFOCAL; PRIONS; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; SPECTROMETRY, FLUORESCENCE;

EID: 84862502597     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037692     Document Type: Article

References (42)

1. Wickner RB, Edskes HK, Maddelein ML, Taylor KL, Moriyama H, (1999) Prions of yeast and fungi. Proteins as genetic material. J Biol Chem 274: 555-558.
2. Chernoff YO, Lindquist SL, Ono B, Inge-Vechtomov SG, Liebman SW, (1995) Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [PSI+]. Science 268: 880-884.
3. Moriyama H, Edskes HK, Wickner RB, (2000) [URE3] Prion Propagation in Saccharomyces cerevisiae: Requirement for Chaperone Hsp104 and Curing by Overexpressed Chaperone Ydj1p. Mol Cell Biol 20: 8916-8922.
4. Lee S, Sowa ME, Choi JM, Tsai FT, (2004) The ClpB/Hsp104 molecular chaperone-a protein disaggregating machine. J Struct Biol 146: 99-105.
5. Tuite MF, Mundy CR, Cox BS, (1981) Agents that cause a high frequency of genetic change from [PSI+] to [psi-] in Sacchromyces cerevisiae. Genetics 98: 691-711.
6. Jung G, Masison DC, (2001) Guanidine hydrochloride inhibits Hsp104 activity in vivo: a possible explanation for its effect in curing yeast prions. Curr Microbiol 43: 7-10.
7. Wegrzyn RD, Bapat K, Newnam GP, Zink AD, Chernoff YO, (2001) Mechanism of prion loss after Hsp104 inactivation in yeast. Mol Cell Biol 21: 4656-4669.
8. Patino MM, Liu JJ, Glover JR, Lindquist S, (1996) Support for the prion hypothesis for inheritance of a phenotypic trait in yeast. Science 273: 622-626.
9. Borchsenius AS, Wegrzyn RD, Newnam GP, Inge-Vechtomov SG, Chernoff YO, (2001) Yeast prion protein derivative defective in aggregate shearing and production of new 'seeds'. EMBO J 20: 6683-6691.
10. DePace AH, Santoso A, Hillner P, Weissman JS, (1998) A critical role for amino-terminal glutamine/asparagine repeats in the formation and propagation of a yeast prion. Cell 93: 1241-1252.
11. Zhou P, Derkatch IL, Liebman SW, (2001) The relationship between visible intracellular aggregates that appear after overexpression of Sup35 and the yeast prion-like elements [PSI+] and [PIN+]. Mol Microbiol 39: 37-46.
12. Song Y, Wu YX, Jung G, Tutar Y, Eisenberg E, et al. (2005) Role for Hsp70 chaperone in Saccharomyces cerevisiae prion seed replication. Eukaryot Cell 4: 289-297.
13. Satpute-Krishnan P, Serio TR, (2005) Prion protein remodelling confers an immediate phenotypic switch. Nature 437: 262-265.
14. Chernoff YO, (2004) Cellular control of prion formation and propagation in yeast. Telling GC, editor. Prions and Prion Diseases: Current Perspectives Norfolk, England: Horizon Biosciences pp. 257-357.
15. Ferreira PC, Ness F, Edwards SR, Cox BS, Tuite MF, (2001) The elimination of the yeast [PSI+] prion by guanidine hydrochloride is the result of Hsp104 inactivation. Mol Microbiol 40: 1357-1369.
16. Ness F, Ferreira P, Cox BS, Tuite MF, (2002) Guanidine hydrochloride inhibits the generation of prion "seeds" but not prion protein aggregation in yeast. Mol Cell Biol 22: 5593-5605.
17. Eaglestone SS, Ruddock LW, Cox BS, Tuite MF, (2000) Guanidine hydrochloride blocks a critical step in the propagation of the prion-like determinant [PSI+] of Saccharomyces cerevisiae. Proc Natl Acad Sci USA 97: 240-244.
18. Byrne LJ, Cox BS, Cole DJ, Ridout MS, Morgan BJ, et al. (2007) Cell division is essential for elimination of the yeast [PSI+] prion by guanidine hydrochloride. Proc Natl Acad Sci U S A 104: 11688-11693.
19. Satpute-Krishnan P, Langseth SX, Serio TR, et al. (2007) Hsp104-dependent remodeling of prion complexes mediates protein-only inheritance. PLoS Biol 5: e24.
20. Kawai-Noma S, Pack C-G, Tsuji T, Kinjo M, Taguchi H, (2009) Single mother-daughter pair analysis to clarify the diffusion properties of yeast prion Sup35 in guanidine-HCl-treated [PSI+] cells. Genes Cells 14: 1045-1054.
21. Wu YX, Greene LE, Masison DC, Eisenberg E, (2005) Curing of yeast [PSI+] prion by guanidine inactivation of Hsp104 does not require cell division. Proc Natl Acad Sci U S A 102: 12789-12794.
22. Mathur V, Hong JY, Liebman SW, (2009) Ssa1 Overexpression and [PIN+] variants cure [PSI+] by dilution of aggregates. J Mol Biol 390: 155-167.
23. Gietz RD, Schiestl RH, (2007) Large-scale high-efficiency yeast transformation using the LiAc/SS carrier DNA/PEG method. Nat Protocols 2: 38-41.
24. Park YN, Masison D, Eisenberg E, Greene LE, (2011) Application of the FLP/FRT system for conditional gene deletion in yeast Saccharomyces cerevisiae. Yeast 28: 673-681.
25. Hung G-C, Masison DC, (2006) N-terminal domain of yeast Hsp104 chaperone is dispensable for thermotolerance and prion propagation but necessary for curing prions by Hsp104 overexpression. Genetics 173: 611-620.
26. Jung G, Jones G, Wegrzyn RD, Masison DC, (2000) A role for cytosolic hsp70 in yeast [[PSI+] prion propagation and [PSI+] as a cellular stress. Genetics 156: 559-570.
27. Greene LE, Park YN, Masison DC, Eisenberg E, (2009) Application of GFP-labeling to study prions in yeast. Protein Pept Lett 16: 635-641.
28. Cox B, Ness F, Tuite M, (2003) Analysis of the generation and segregation of propagons: entities that propagate the [PSI+] prion in yeast. Genetics 165: 23-33.
29. Ghaemmaghami S, Huh W-K, Bower K, Howson RW, Belle A, (2003) Global analysis of protein expression in yeast. Nature 425: 737-741.
30. Byrne LJ, Cole DJ, Cox BS, Ridout MS, Morgan BJT, et al. (2009) The number and transmission of [PSI+] prion seeds (propagons) in the yeast Saccharomyces cerevisiae. PLoS ONE 4: e4670.
31. Derdowski A, Sindi SS, Klaips CL, DiSalvo S, Serio TR, (2010) A size threshold limits prion transmission and establishes phenotypic diversity. Science 330: 680-683.
32. Grimminger V, Richter K, Imhof A, Buchner J, Walter S, (2004) The prion curing agent guanidinium chloride specifically inhibits ATP hydrolysis by Hsp104. J Biol Chem 279: 7378-7383.
33. Schirmer EC, Ware DM, Queitsch C, Kowal AS, Lindquist SL, (2001) Subunit interactions influence the biochemical and biological properties of Hsp104. Proc Natl Acad Sci U S A 98: 914-919.
34. Newnam GP, Wegrzyn RD, Lindquist SL, Chernoff YO, (1999) Antagonistic Interactions between Yeast Chaperones Hsp104 and Hsp70 in Prion Curing. Mol Cell Biol 19: 1325-1333.
35. Kawai-Noma S, Ayano S, Pack C-G, Kinjo M, Yoshida M, et al. (2006) Dynamics of yeast prion aggregates in single living cells. Genes Cells 11: 1085-1096.
36. Elsner M, Hashimoto H, Simpson JC, Cassel D, Nilsson T, et al. (2003) Spatiotemporal dynamics of the COPI vesicle machinery. EMBO Rep 4: 1000-1004.
37. Wang Z, Shah JV, Chen Z, Sun CH, Berns MW, (2004) Fluorescence correlation spectroscopy investigation of a GFP mutant-enhanced cyan fluorescent protein and its tubulin fusion in living cells with two-photon excitation. J Biomed Opt 9: 395-403.
38. Bagriantsev SN, Gracheva EO, Richmond JE, Liebman SW, (2008) Variant-specific [PSI+] infection is transmitted by Sup35 polymers within [PSI+] aggregates with heterogeneous protein composition. Mol Biol Cell 19: 2433-2443.
39. Erjavec N, Larsson L, Grantham J, Nystrom T, (2007) Accelerated aging and failure to segregate damaged proteins in Sir2 mutants can be suppressed by overproducing the protein aggregation-remodeling factor Hsp104p. Genes Dev 21: 2410-2421.
40. Tanaka M, Collins SR, Toyama BH, Weissman JS, (2006) The physical basis of how prion conformations determine strain phenotypes. Nature 442: 585-589.
41. Roll-Mecak A, Vale RD, (2008) Structural basis of microtubule severing by the hereditary spastic paraplegia protein spastin. Nature 451: 363-367.
42. Paushkin SV, Kushnirov VV, Smirnov VN, Ter-Avanesyan MD, (1996) Propagation of the yeast prion-like [PSI+] determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor. EMBO J 15: 3127-3134.